2015 QUARTERLY WEBINAR SERIES
Child Neurology Conversations from the Parent, Provider, and Advocate Voices
DIAGNOSING, TREATING, AND MANAGING INFANTILE SPASMS TOGETHER

Register today to join the conversation, ask questions, and connect with other parents and partners in care!

      Monday, November 2, 2015 @ 2pm (EST) * Free


Click the button to register.  
Webinar Description: 

Infantile spasms (IS) is a rare seizure disorder that occurs in young children, usually under one year of age. The average age of onset is around four months, but some children may experience spasms as early as one month. A few children may begin as late as two years. Only about 2,500 children in the United States are diagnosed each year with IS. It often has a very subtle appearance, so it is difficult for parents to recognize that it is a serious problem. Not only is it difficult for the parent to realize that this is a seizure disorder, it is also challenging for pediatricians. Infantile spasms are so uncommon that most pediatricians will see only one or two IS cases during all their years of practice.  Also IS often looks similar to common disorders such as a normal startle reflex, colic, or reflux.  It is very important to recognize that a child has IS as soon as it begins because:
  • there are medications that may control the spasms
  • the longer the spasms last before they are treated and controlled, the poorer the child may do developmentally
Children who develop IS are at great risk for developmental disability and autism, but some children will do well if they are treated early.  Because the spasms may be subtle, the diagnosis may be delayed for weeks or months. While there are practice guidelines to educate child neurologists and other providers on the need for timely diagnosis and treatment options of IS, there are gaps in current care provision. Additionally, there are continued variants in clinical management of IS, specifically in the areas of first-line therapies, dosage regimens, and treatment duration. These variations in practice - if not well communicated - may lead to caregiver confusion and frustration, which, ultimately, has the opportunity to erode the family-professional partnership. This relationship is critical to the long-term provision of quality, compassionate care necessary for children living with IS.
 
Join experts from the child neurology community for a 60-minute webinar that will focus on the provider/caregiver relationship and ways to improve communication and understanding during diagnosis, treatment, and management of IS to ensure optimal care for these young children. In this webinar, you will learn:
  • What information caregivers can convey to providers to ensure correct diagnosis
  • What questions caregivers most often have for providers related to treatment choices
  • Recommended first-line therapies for treating IS based on current evidence
  • Resources available to assist in supporting caregivers after the diagnosis of IS and throughout on-going management
  • How upcoming initiatives to promote the need for timely diagnosis and ongoing research efforts related to disease management can improve quality of care
To learn about Infantile Spasms Awareness Week (ISAW) 2015 (December 1-7), visit 


 
PRESENTER INFORMATION 

Danielle Boyce: Danielle is a mother of two children, including a son, Charlie, who had infantile spasms. She holds a BA in political science and a Master's in Public Health with a concentration in epidemiology.  She currently works as a Senior Research Data Analyst for Johns Hopkins University School of Medicine, Division of Pulmonary and Critical Care Medicine.  Danielle has co-authored numerous peer-reviewed articles. 
 
Danielle is an active patient advocate, serving many roles in the epilepsy community.  She is the Executive Director of Infantile Spasms Community, a caregiver-to-caregiver support organization for families of children diagnosed with infantile spasms.  She also serves on the board of directors of the Lennox-Gastaut Syndrome Foundation, acts as an FDA Patient Representative for infantile spasms, sits on the Steering Committee for the Rare Epilepsy Network, and conducts family support workshops on a variety of epilepsy-related topics.  She is particularly interested in sibling support issues and authored a children's book, "Charlie's Teacher," inspired by her daughter's experiences as the sibling of a child who receives home-based therapies.  Danielle also volunteers for Autism Inclusion Resources, an organization that helps families affected by autism to venture out into their community.  Danielle's inclusive special education programming work with a Baltimore museum was featured at a national museum conference in 2013. In her spare time, Danielle is an avid museum visitor and art lover.  Danielle and Charlie recently ran a 5k race together with Charlie in his wheelchair.  They plan to run a half marathon together in 2016.

Kari Luther Rosbeck: President and CEO of the Tuberous Sclerosis Alliance, Kari has been with the organization since June 2001. During her tenure as CEO since November 2007, the TS Alliance has established a Drug Screening Program, to foster collaboration with industry and academia in order to move treatments for tuberous sclerosis complex (TSC) forward in a more expedited way, and played an active role in the development of the first clinical trial for neurocognition in TSC, which led to the establishment of the a TSC Clinical Research Consortium now involved in four clinical studies and trials.  In just the past six years, there have been FDA approvals for two therapies to combat infantile spasms, the most catastrophic form of epilepsy that up to a third of infants with TSC may experience, and two approvals of a drug with a TSC indication, specifically SEGA and kidney tumors associated with TSC.  The organization has taken an active role in educating the TSC community about clinical trials in order to diminish the time for recruitment.

Ms. Rosbeck previously oversaw the national volunteer outreach program and was responsible for fund development. She developed and implemented a vast national network of more than 30 volunteer branches called Community Alliances; increased volunteer participation from 90 individuals to more than 2,000; and through her involvement in special events and major gift fundraising, helped increase the annual revenue by more than 50%. Rosbeck has been involved in nonprofit fundraising and volunteer management for over 25 years. Previously, she served as a Regional Director for International Service Agencies (now known as Global Impact), where she developed the Midwest regional volunteer program while raising $1.3 million in revenue. She was also the Manager of Corporate and Foundation Relations at American Refugee Committee in Minneapolis, where she was responsible for major gift development, special event corporate sponsorship and volunteer coordination.

John M. Pellock, MD: 
Professor of Neurology, Pediatrics, Pharmacy and Pharmaceutics at Virginia Commonwealth University, in Richmond, Virginia since 1995. He served as Chairman of the Division of Child Neurology from 1995-2014.  He currently is the Senior Associate Dean for Continuing Medical Education and CEO of UHS-PEP.
 
Dr. Pellock is a diplomate of the American Board of Pediatrics and of the American Board of Psychiatry and Neurology with Special Qualification in Child Neurology.  He is a fellow of the American Academy of Neurology and the American Academy of Pediatrics and is a member of several professional organizations including the American Neurological Association, The Child Neurology Society, and the American Epilepsy Society where he is Past President. He has been included in Best Doctors in America and Who's Who International and America. Dr. Pellock has been Principal Investigator for over 100 trials evaluating epilepsy treatments in children and adults, and a co-investigator for many others.  He is funded by the NIH for various studies in pediatric and adult epilepsy. Dr. Pellock has been involved in antiepileptic drug development and studying epilepsy in children for over thirty years.  Dr. Pellock is a member of the editorial board of the Journal of Child Neurology, Pediatric Neurology, Epileptic Disorders, Journal of Pediatric Pharmacology and Therapeutics and serves as reviewer of a number of journals including the New England Journal of Medicine, Neurology, Epilepsia, and Pediatrics.  He has published extensively (greater than 250 articles and books) and lectured widely on pediatric epilepsy and has conducted clinical research in anticonvulsant therapy. He received the 2004 J. Kiffin Penry Award for Excellence in Neurology from the American Epilepsy Society and was invited to deliver the Judith Hoyer Lecture in 2013.
 
Dr. Pellock received his undergraduate degree from Johns Hopkins University, a Master of Science in biology at Fairleigh Dickinson University in Teaneck, New Jersey and his medical degree from St. Louis University in St. Louis, Missouri.  He completed an internship and residency in pediatrics at the Medical College of Virginia, VCU and a fellowship in pediatric neurology at Columbia Presbyterian Medical Center in New York, New York.  Following training, he served in the U.S. Navy as LT CDR at National Naval Medical Center in Bethesda, Maryland following which he began his tenure at Medical College of Virginia/Virginia Commonwealth University in 1978. He is married to Mary L. (Miller) Pellock, has a son, daughter and one grandchild.

Amy Brin Miller:  Amy has been working on behalf of children with special needs and their families for over 13 years. She is a pediatric advanced practice nurse; Board Certified in Pediatrics and Hospice and Palliative Medicine. Miller has been responsible for the development and administration of various tertiary, ambulatory and community-based pediatric palliative and hospice programs in several states. Miller graduated with honors from Vanderbilt University, with a Masters of Science in Nursing. She has a previous Masters in Arts in Communication from Miami University. She is a nationally published author, notably in Pediatrics, as well as in a featured end of life chapter in Advanced Practice Nursing of Adults in Acute Care. In 2011, Miller authored the Pediatric Hospice chapter within the American Academy of Hospice and Palliative Medicine, The Hospice Medical Director Manual. Miller served as adjunct faculty at Vanderbilt University School of Nursing and University of Kentucky's College of Nursing. In 2009, Miller began her consulting career with the American Academy of Pediatrics regarding building systems of care for children with special needs, as well as children's hospitals and community-based agencies related to establishing home health and hospice service lines. In 2013, she began consulting with the Child Neurology Foundation regarding transitioning youth with neurologic disease from the pediatric to the adult healthcare system. Miller currently serves as Executive Director for the Child Neurology Foundation. 

Child Neurology Foundation
| 201 Chicago Avenue #200|Minneapolis, MN 55415 |
                                  Copyright © 2015. All Rights Reserved.